SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-23-255663
Filing Date
2023-10-13
Accepted
2023-10-13 07:11:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d519703dsc14d9.htm SC 14D9 446616
2 GRAPHIC g519703g87x46.jpg GRAPHIC 27463
  Complete submission text file 0001193125-23-255663.txt   483040
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filed by) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-91575 | Film No.: 231323887
SIC: 2834 Pharmaceutical Preparations